Investigational Drug Information for BLD-0409
✉ Email this page to a colleague
What is the drug development status for BLD-0409?
BLD-0409 is an investigational drug.
There have been 5 clinical trials for BLD-0409.
The most recent clinical trial was a Phase 1 trial, which was initiated on May 31st 2022.
The most common disease conditions in clinical trials are Fibrosis, Non-alcoholic Fatty Liver Disease, and Liver Diseases. The leading clinical trial sponsors are Blade Therapeutics and [disabled in preview].
There is one US patent protecting this investigational drug and forty-five international patents.
Summary for BLD-0409
| US Patents | 1 |
| International Patents | 45 |
| US Patent Applications | 9 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2022-05-31) |
| Vendors | 16 |
Recent Clinical Trials for BLD-0409
| Title | Sponsor | Phase |
|---|---|---|
| RESPIRARE Phase 2 Study of Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) | Blade Therapeutics | Phase 2 |
| Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers | Blade Therapeutics | Phase 1 |
| Healthy Volunteer Study Comparing Tablet and Oral Solution Formulations | Blade Therapeutics | Phase 1 |
Clinical Trial Summary for BLD-0409
Top disease conditions for BLD-0409
Top clinical trial sponsors for BLD-0409
US Patents for BLD-0409
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| BLD-0409 | ⤷ Subscribe | Autotaxin inhibitors and uses thereof | SABRE THERAPEUTICS LLC (South San Francisco, CA) | ⤷ Subscribe |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BLD-0409
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BLD-0409 | Australia | AU2016268250 | 2035-05-27 | ⤷ Subscribe |
| BLD-0409 | Australia | AU2020239656 | 2035-05-27 | ⤷ Subscribe |
| BLD-0409 | Australia | AU2022228098 | 2035-05-27 | ⤷ Subscribe |
| BLD-0409 | Brazil | BR112017025420 | 2035-05-27 | ⤷ Subscribe |
| BLD-0409 | Canada | CA2986759 | 2035-05-27 | ⤷ Subscribe |
| BLD-0409 | China | CN107921048 | 2035-05-27 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
